FDA Warning Letter — Ballard Plaza Pharmacy I, Inc.

Case 507776 — FEI 3006317860

The FDA took a Warning Letter action against Ballard Plaza Pharmacy I, Inc. on August 1, 2017 (Seattle, WA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Ballard Plaza Pharmacy I, Inc.
Date
August 1, 2017
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
Seattle, WA (United States)